Switch to:
More From Other Websites
Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing Oct 22 2014
The Zacks Analyst Blog Highlights: Pacific Biosciences of California, Teva Pharmaceutical... Oct 22 2014
[$$] FDA Panel Recommends Expanded Approval of CF Drug Oct 21 2014
FDA panel votes to expand use of Vertex cystic fibrosis drug Oct 21 2014
4:49 pm Vertex Pharm confirms that FDA Advisory Committee recommends approval of KALYDECO... Oct 21 2014
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic... Oct 21 2014
Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? Oct 21 2014
Vertex Faces a Litmus Test for its Cystic Fibrosis Combo Treatment Oct 21 2014
Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? Oct 20 2014
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer Oct 15 2014
Vertex to Announce Third Quarter 2014 Financial Results on October 28 Oct 14 2014
Bank Of America Is Impressed By Takeaways From Vertex Pharmaceuticals Conference Call Oct 14 2014
3 Stocks Improving Performance Of The Drugs Industry Oct 13 2014
UPDATE: Piper Jaffray Upgrades Vertex Pharmaceuticals Ahead Of Expected Combination Approvals Oct 13 2014
Vertex Pharmaceuticals (VRTX) Updates on Kalydeco Studies Oct 10 2014
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple... Oct 09 2014
Why You Shouldn't Bet Against Vertex Pharmaceuticals (VRTX) Stock Oct 09 2014
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update Oct 08 2014
Better-than-expected jobs data helped benchmarks end in the green on Friday Oct 06 2014
Johnson & Johnson Bets $1.75 Billion On Alios Buy Sep 30 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK